The Prevalence of Polycystic Ovary Syndrome in a Community Sample of Iranian Population: Iranian PCOS Prevalence Study

    January 2011 in “ Reproductive Biology and Endocrinology ”
    Fahimeh Ramezani Tehrani, Masoumeh Simbar, Maryam Tohidi, Farhad Hosseinpanah, Fereidoun Azizi
    Image of study
    TLDR About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.
    In 2011, a study involving 1126 Iranian women aged 18-45 found that the prevalence of polycystic ovary syndrome (PCOS) varied significantly based on the diagnostic criteria used. The prevalence rates were 7.1% using the National Institute of Health (NIH) criteria, 11.7% with the Androgen Excess Society (AES) criteria, and 14.6% according to the Rotterdam consensus (Rott.) criteria. The study highlighted that using the Rotterdam criteria could more than double the reported prevalence of PCOS in community screenings. Additionally, the study revealed that primary infertility rates were higher in women with PCOS and that regional prevalence ranged from 2.2% to 26%, indicating the influence of different diagnostic criteria and recruitment methods. The authors emphasized the need for a consistent and clear method for defining and screening PCOS to enhance the comparability of research findings.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results